|
NASDAQ Biotechnology Index SWAP Bank of ... |
|
15.83% |
|
|
|
|
|
|
|
|
|
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
3.05% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
|---|
| AMGN |
Amgen Inc. |
0 |
2.81% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
35.91% |
45.64% |
|---|
| AZN |
AstraZeneca PLC |
0 |
1.36% |
|
|
|
|
|
N/A |
0.00% |
23.05% |
14.57% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
|---|
| BIIB |
Biogen Inc. |
0 |
0.78% |
|
|
|
|
|
N/A |
0.00% |
28.33% |
18.82% |
|---|
| ILMN |
Illumina, Inc. |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
39.56% |
23.84% |
|---|
| ARGX |
argenx SE |
0 |
0.71% |
|
|
|
|
|
N/A |
0.00% |
29.52% |
28.33% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
58.67% |
104.61% |
|---|
| MRNA |
Moderna, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
56.54% |
10.47% |
|---|
| VTRS |
Viatris Inc. |
0 |
0.52% |
|
|
|
|
|
N/A |
0.00% |
36.13% |
41.13% |
|---|
| SNY |
Sanofi |
0 |
0.52% |
|
|
|
|
|
N/A |
0.00% |
27.21% |
20.84% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
27.77% |
8.48% |
|---|
| INCY |
Incyte Corporation |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
29.49% |
27.75% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
82.88% |
23.35% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
39.49% |
50.37% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
72.86% |
66.33% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
117.60% |
53.76% |
|---|
| RPRX |
Royalty Pharma plc |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
139.51% |
42.74% |
|---|
| BNTX |
BioNTech SE |
0 |
0.39% |
|
|
|
|
|
N/A |
0.00% |
43.87% |
30.54% |
|---|
| MEDP |
Medpace Holdings, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
35.62% |
18.15% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
77.99% |
47.74% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
32.60% |
25.01% |
|---|
| ITCI |
INTRA-CELLULAR THERAPIES INC |
|
0.31% |
|
|
|
|
|
|
|
|
|
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
33.05% |
49.22% |
|---|
| ASND |
Ascendis Pharma A/S |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
49.82% |
|---|
| BGNE |
BEIGENE LTD-ADR |
|
0.29% |
|
|
|
|
|
|
|
|
|
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
59.90% |
101.22% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
54.00% |
42.22% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
61.24% |
39.57% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
42.17% |
37.99% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
79.89% |
34.47% |
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
94.29% |
1.14% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
46.53% |
42.27% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
64.17% |
24.99% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
46.28% |
35.21% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
45.83% |
31.48% |
|---|
| ALKS |
Alkermes plc |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
58.11% |
42.47% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
57.07% |
59.43% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
50.16% |
23.91% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
65.73% |
38.96% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
49.82% |
22.56% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
66.90% |
7.26% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
49.58% |
6.95% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
57.42% |
15.18% |
|---|
| GH |
Guardant Health, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
62.38% |
26.94% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
65.50% |
40.18% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
112.32% |
38.97% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
107.70% |
69.67% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
49.35% |
16.68% |
|---|
| VRNA |
Verona Pharma plc |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
262.94% |
4.52% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
57.68% |
34.39% |
|---|
| NVCR |
NovoCure Limited |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
55.89% |
16.20% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
74.15% |
18.96% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
59.32% |
28.55% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
681.57% |
28.25% |
|---|
| MRUS |
Merus N.V. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
67.26% |
39.10% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
833.65% |
48.16% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
71.14% |
41.48% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
435.76% |
49.91% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
90.33% |
49.69% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
67.79% |
66.63% |
|---|
| SWTX |
SPRINGWORKS THERAPEUTICS INC |
|
0.10% |
|
|
|
|
|
|
|
|
|
|---|
| LEGN |
Legend Biotech Corporation |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
49.87% |
20.04% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
124.19% |
23.60% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
196.89% |
54.10% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
116.75% |
15.19% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
72.71% |
31.33% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
451.62% |
28.28% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
262.17% |
35.70% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
75.44% |
34.69% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
45.69% |
7.98% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
446.29% |
27.56% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
225.35% |
14.69% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
41.18% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
62.46% |
39.19% |
|---|
| GERN |
Geron Corporation |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
354.23% |
31.50% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
97.22% |
55.52% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
78.18% |
8.72% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
39.12% |
27.88% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
133.27% |
40.59% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
73.12% |
19.29% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
79.15% |
69.17% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
185.01% |
21.54% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
50.34% |
51.96% |
|---|
| WVE |
Wave Life Sciences Ltd. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
517.65% |
20.05% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
123.91% |
54.84% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
64.73% |
11.25% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
351.89% |
83.68% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
56.31% |
49.77% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
298.34% |
35.51% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
166.51% |
33.05% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
88.08% |
44.45% |
|---|
| FTRE |
Fortrea Holdings Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
155.98% |
51.54% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
155.10% |
39.62% |
|---|
| GPCR |
Structure Therapeutics Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
121.07% |
52.35% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
63.62% |
80.33% |
|---|
| TXG |
10x Genomics, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
73.82% |
22.84% |
|---|